SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral submits analyst meet intimation

18 Jan 2024 Evaluate
With reference to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that Q3 FY24 Earnings Conference Call is organized by the Company on Wednesday, 24th January, 2024 at 16:30 hrs (India Time) as per details attached.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1137.70 -8.35 (-0.73%)
16-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2742.15
BASF India 3455.30
Tata Chemicals 729.60
Pidilite Inds. 1571.05
Deepak Nitrite 1642.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: